Bargieri, Daniel Youssef 
; Leite, Juliana A.; Lopes, Stefanie C. P.; Sbrogio-Almeida, Maria Elisabete; Braga, Catarina Joelma Magalhães; Ferreira, Luís Carlos de Souza ; Soares, Irene da Silva ; Costa, Fabio T. M.; Rodrigues, Mauricio M.
Source: Vaccine. Unidades: ICB, FCF
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARGIERI, Daniel Youssef et al. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, v. 28, n. 16, p. 2818-2826, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2010.02.004. Acesso em: 14 nov. 2024.APA
Bargieri, D. Y., Leite, J. A., Lopes, S. C. P., Sbrogio-Almeida, M. E., Braga, C. J. M., Ferreira, L. C. de S., et al. (2010). Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine, 28( 16), 2818-2826. doi:10.1016/j.vaccine.2010.02.004NLM
Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004Vancouver
Bargieri DY, Leite JA, Lopes SCP, Sbrogio-Almeida ME, Braga CJM, Ferreira LC de S, Soares I da S, Costa FTM, Rodrigues MM. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium [Internet]. Vaccine. 2010 ; 28( 16): 2818-2826.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.vaccine.2010.02.004
